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Association between telomere length 
in peripheral blood leukocytes and risk 
of ischemic stroke in a Han Chinese 
population: a linear and non-linear Mendelian 
randomization analysis
Weijie Cao1†, Deqiang Zheng1†, Jie Zhang1, Anxin Wang2,3, Di Liu1, Jinxia Zhang1, Manjot Singh4, 
Isinta Elijah Maranga1, Mingyang Cao1, Lijuan Wu1, Manshu Song4, Wei Wang1,4* and Youxin Wang1,4* 
Abstract 
Background: Many contradictory conclusions pertaining to the telomere length in peripheral leukocyte chromo-
somes as a potential biomarker for ischemic stroke (IS) risk have been reported by the various observational studies in 
previous years. This study aims to investigate whether the leukocyte telomere length is associated with an increased 
IS risk or not, based on the Mendelian randomization (MR) approach.
Methods: Based on the NHGRI-EBI GWAS Catalog database, the Chinese online genetic database as well as the 
previous published studies, twelve single nucleotide polymorphisms (SNPs) with minor allele frequency ≥ 0.05 were 
selected and the leukocyte telomere length was measured in 431 first-ever IS patients and 304 healthy controls 
(quantitative polymerase chain reaction). To explore linear and non-linear effect of telomere length on the IS risk, we 
preformed the linear MR analysis (the inverse-variance weighted method, the maximum likelihood method, and the 
mode-based estimation method), and the non-linear MR analysis (semiparametric method with three tests for non-
linearity, including the quadratic test, Cochran’s Q test, and the fractional polynomial test).
Results: Two verified SNPs (rs11125529 and rs412658) were chosen as instrumental variables. In linear MR analysis, 
the adjusted odds ratios and 95% confidence intervals of IS for genetically predicted telomere lengths, based on 
the two SNPs, were 1.312 (0.979 to 1.759), 1.326 (0.932 to 1.888) and 1.226 (0.844 to 1.781) for the inverse-variance 
weighted method, the maximum likelihood method, and the mode-based estimation method, respectively. Three 
tests for nonlinearity failed to reject the null exactly, indicating that the relationship between telomere length and IS 
risk is unlikely to be non-linear.
Conclusion: This MR study based on individual data does not provide strong evidence for a positive linear or non-
linear effect of telomere length on the IS risk.
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Background
In China, stroke is one of the leading causes of death, and 
about 78% of all strokes are ischemic stroke (IS) [1]. IS 
is a complex syndrome triggered by cerebral embolism, 
with its major etiological subtypes being large artery 
stroke, cardioembolic stroke as well as the small vessel 
stroke [2]. Chronological age is one of critical factors in 
IS pathology but is not considered to be a causal factor 
[3]. This relationship might reflect the impact of biologi-
cal aging, particularly, in regards to the accumulation of 
endothelial and vascular damage over time [4]. Telomeres 
are specialized DNA–protein complexes at linear chro-
mosome ends in eukaryotes, and have been considered 
as a marker of biological aging at both the cellular and 
organism level [5, 6]. They safeguard genome stability by 
preventing DNA degradation and fusion at chromosomal 
termini [7]. The DNA component that include TTA GGG 
nucleotide repeats progressively shortens with each cell 
division. Telomere shortening to a critical length eventu-
ally induces cell senescence and programmed cell death, 
thereby they can be likened to a ‘mitotic clock’ reflecting 
the amount of cellular turnover within an individual [7]. 
Furthermore, the telomere attrition rate increased due 
to oxidative stress and inflammation, both of which are 
implicated as major mechanisms underlying biological 
aging [8–10]. Because of its presumed effect on biologi-
cal aging, telomere length (TL) has been proposed as a 
potential biomarker for IS [11]. In addition to biological 
aging, TL shortening has been linked to various risk fac-
tors of stroke, including obesity, smoking, alcohol intake, 
psychological stress and depression [11].
Conventional observational studies have shown incon-
clusive associations of telomere shortening and the risk 
of stroke. Consistently, several original studies reported 
positive association between telomere shortening and the 
risk of stroke [12–14]. In contrast, evidence also suggests 
that shorter telomeres were not significantly associated 
with stroke risk [15–17]. However, meta-analysis have 
shown that there were less certain results to support the 
relationship between TL and stroke [18, 19].
Randomized controlled trials of interventions specific 
to TL have not yet been done in relation to stroke out-
comes. In the absence of such trials, Mendelian randomi-
zation (MR) analysis focused on genetic instrument can 
be used to investigate the causality from routinely obser-
vational studies [20]. Based on two-sample MR design, 
three MR analyses have been performed to investigate 
the association between shorter telomeres and stroke 
risk and showed contradictory conclusions. First, a MR 
study showed that shorter telomeres lead to a margin-
ally significantly decreased odds of stroke in individual-
level data [21]. Another two MR studies suggested that 
TL may be a marker of IS and its subtypes rather than 
a cause [22, 23]. Two-sample MR typically assume that 
the exposure-outcome association is linear or log-linear 
[24]. Therefore, a non-linear TL-IS relationship, such as 
U-shaped, cannot be detected through this design. To 
tackle this nonlinearity problem, one-sample MR analysis 
can be used to explore the non-linear effect relating TL to 
IS [25]. In this present study, we performed one-sample 
MR analysis with individual-level data in a Han Chinese 
population to decipher the linear and non-linear causal 
role of TL in the IS risk, and to provide insight into the 
potential mechanisms.
Methods
Study population
All participants were recruited from Jidong Oil-field 
Hospital, Chinese National Petroleum, and Beijing Tian-
tan Hospital, Capital Medical University, during 2010–
2013. A total of 755 participants aged 18 or above were 
found to be eligible. All participants who met any of the 
following criteria were excluded from the study: (1) his-
tory of mental illness or infectious disease; (2) history of 
aneurysm caused by cerebral infarction, cerebral haem-
orrhage or other cerebrovascular diseases, congenital 
heart disease, acute myocardial infarction, liver disease, 
renal failure, malignant tumour, chronic obstructive pul-
monary disease, rheumatoid arthritis, or other diseases; 
and (3) pregnant or lactating women. All first‐ever IS 
patients were diagnosed according to the World Health 
Organization criteria [26]. In this study, 20 participants 
of non-Han Chinese descent were subsequently excluded. 
A total of 431 patients with IS and 304 healthy subjects 
were included in the final analysis.
This study was approved by the Ethics Committee of 
Capital Medical University, China (No. 2016SY23). This 
study was in accordance with the principles of the Decla-
ration of Helsinki. All participants provided their written 
informed consent before taking part in this study.
Leukocyte telomere length measurement
Blood samples were collected and processed accord-
ing to the standardized protocol. Following 10  h. of 
overnight fasting, blood samples were collected by 
venipuncture in two different tubes containing an anti-
coagulant and a coagulant respectively. Samples were 
processed within 8 h. and stored at -80C until further 
Keywords: Telomere length, Ischemic stroke, Mendelian randomization analysis, Disease biomarker
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measurement. Given that whole blood TL is a proxy 
for tissue-specific TL for many tissues, and blood TL is 
a proxy for TL in some tissues in epidemiological stud-
ies [27], in this study we measured TL in whole blood, 
but not different types of leukocytes.
Serum samples were used to measure the biochemi-
cal indices, and blood cells were used to extract the 
genomic DNA. Based on automated nucleic acid 
purification platform (BioTeke, AU1001-32, Beijing, 
China), genomic DNA was extracted from the 200  μl 
of frozen blood cells using the magnetic bead-based 
method for concentrating DNA (The Genomic DNA 
Magnetic Beads Kit, AU18016, BioTeke, Beijing, 
China). DNA concentration and purity were deter-
mined using a Nanodrop (ND-8000, Thermo Scien-
tific, USA) and then normalized to 5 ng/μl in TE buffer 
(1  mM EDTA, 10  mM Tris–HCl [pH 8.0]). Absolute 
TL of each chromosome end of the peripheral leuko-
cytes was measured by using a validated quantitative 
polymerase chain reaction (qPCR) on the method 
reported by O’Callaghan with modification [28, 29]. 
A single copy reference gene (36B4) which encodes 
the acidic ribosomal phosphoprotein P0, was used to 
normalize the quantity of the input DNA. Comparing 
telomere-to-36B4 ratio to reference DNA of known 
TL reflects the absolute length of the telomeres. The 
master mix was prepared using Applied Biosystems 
reagents. Primer concentrations were: TelF 200  nM, 
TelR 200 nM, 36B4F 300 nM, and 36B4R 500 nM. The 
primer sequences (5′–3′) were as follows:
TelF CGG TTT GTT TGG GTT TGG GTT TGG GTT TGG 
GTT TGG GTT 
TelR GGC TTG CCT TAC CCT TAC CCT TAC CCT TAC 
CCT TAC CCT 
36B4F CAG CAA GTG GGA AGG TGT AATCC 
36B4R CCC ATT CTA TCA TCA ACG GGT ACA A
Analysis of both telomere and 36B4 in experimen-
tal samples and reference DNA were run in triplicates 
using 5 ng DNA and both telomere and 36B4 amplifi-
cations were performed on the same run. A no tem-
plate control of nuclease-free water was included in 
each run. In brief, qPCR was performed in 0.1 ml tubes 
on the Applied Biosystems QuantStudio 3 Real-Time 
PCR System (Thermo Scientific, USA), with the ther-
mal cycling profile for both telomere and 36B4 ampli-
fications: 2 min at 50 °C, 2 min at 95 °C, followed by 35 
cycles of 95 °C for 15 s, 61 °C for 1 min, followed by a 
melt curve. The no template controls in all runs were 
no amplification. The melt curve should produce only 
one single distinct peak. Standard deviation for the Ct-
value in replicates were less than 0.5. The inter-coef-
ficients of variance for the Ct-value was less than 5%.
Genotyping
Single nucleotide polymorphisms (SNPs) were selected 
from the NHGRI-EBI GWAS Catalog (https ://www.ebi.
ac.uk/gwas) and the online genetic database (https ://
www.ensem bl.org) according to reported associations 
with TL and minor allele frequency (MAF) ≥ 0.05. Only 
one SNP (rs17653722) is reported in population of Chi-
nese descent and other TL-related SNPs were based on 
the European ancestry. The exclusion of association 
could be confirmed in online software PhenoScanner 
(https ://www.pheno scann er.medsc hl.cam.ac.uk/pheno 
scann er). Finally, twelve SNPs (rs11125529, rs6772228, 
rs10936599, rs7726159, rs9420907, rs17653722, 
rs3027234, rs8105767, rs409627, rs412658, rs6028466, 
rs755017) were selected for analysis. SNP genotyping was 
performed on these SNPs using the Sequenom Massarray 
iPLEX platform (Agena Bioscience, Inc., San Diego, CA, 
USA).
Variables
Demographic characteristics of participants includ-
ing age, gender, smoking, drinking, height, weight, body 
mass index (BMI), systolic blood pressure (SBP), dias-
tolic blood pressure (DBP), were collected by question-
naire survey and physical examination. Biochemical data 
including fasting plasma glucose (FPG), triglycerides 
(TG), total cholesterol (TC), high‐density lipoprotein 
cholesterol (HDL‐C), low‐density lipoprotein cholesterol 
(LDL‐C), apolipoprotein A1 (ApoA1), apolipoprotein B 
(ApoB) were all tested via standard methods in the clini-
cal laboratory of Beijing Tiantan Hospital. TL measure-
ment and SNP genotyping were performed by laboratory 
personnel according to the standardized protocol.
Statistical analysis
Demographic and clinical characteristics were repre-
sented as the mean ± standard deviation (SD) for con-
tinuous variables underlying the normal distribution; 
otherwise, the median (interquartile range) was used. 
Categorical variables were represented as frequency (per-
centage). The between-group differences of continuous 
variables were tested by the t test or the Mann–Whitney 
U test. The chi‐squared test was used to compare the pro-
portions for categorical variables, and to test for Hardy–
Weinberg equilibrium.
The genetic variant or genetic risk score (GRS) acts as 
an instrumental variable in MR analysis if: (1) they are 
truly associated with TL; (2) they are independent of 
other factors (confounders); and (3) they can only influ-
ence IS risk via the causal effect of the TL. All association 
of instrument variables with TL and other risk factors, 
which were susceptible to reverse association, were 
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limited to health controls. Principal analyses assumed 
over-dominant effects (heterosis), with subsidiary analy-
ses of other genetic models (dominant, recessive, co-
dominant and additive model).
The β coefficients were obtained from the linear regres-
sion model with natural log-transformed TL (ln TL). 
The percentage difference in TL with risk genotype was 
obtained from [exp (β) − 1)] × 100. Then, the linear MR 
estimates for ln TL on the IS risk were calculated by the 
inverse-variance weighted method, the maximum likeli-
hood method, and the mode-based estimation method, 
adjusting for age, sex, and other confounders (smoking 
status, drinking status, and levels of BMI, SBP, DBP, FPG, 
TG, TC, HDL-C, LDL-C, ApoA1, ApoB). All results were 
presented as the odds ratio (OR) of IS per 10% decrease 
in TL. Three tests for non-linearity of the semiparamet-
ric method (the fractional polynomial method and the 
piecewise linear method) were applied: the quadratic 
test, which assesses for a linear trend among the localised 
average causal effect (LACE) estimates, Cochran’s Q test, 
which assesses whether LACE estimates differ more than 
would be expected by chance, and the fractional polyno-
mial test, which assesses whether the fractional polyno-
mial model of degree 1 fits LACE estimates better than 
the linear model [25].
For all analyses, a two‐tailed P value < 0.05 was consid-
ered to be statistically significant. All statistical analyses 
were performed using R version 3.5.3 (R Foundation for 
Statistical Computing, Vienna, Austria).
Results
Participant characteristics
Demographic and clinical characteristics were described 
in Table  1. Among 735 participants (374 men and 
361 women), the median age of the study population 
was 54  years  (P25 44  years,  P75 61  years) in all subjects, 
47  years (35 to 59  years) in controls, and 57  years (49 
to 63 years) in IS patients. Most of the IS patients were 
older males with smoking and drinking habits and higher 
weight, BMI, SBP, DBP, TG levels and lower TC, HDL‐C, 
ApoA1, ApoB levels. The levels of TL, height, FPG, 
LDL‐C, and ApoB/ApoA1 ratio were not statistically 
Table 1 Characteristics of the study population
TL telomere length, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TG triglycerides, TC total cholesterol, 
HDL‐C high‐density lipoprotein cholesterol, LDL‐C low‐density lipoprotein cholesterol, ApoA1 apolipoprotein A1, ApoB apolipoprotein B
* P < 0.05 is statistically significant
Parameters Controls (n = 304) Cases (n = 431) P
Age, years 47 (35, 59) 57 (49, 63) 1.736 × 10–19*
Gender, n (%) 2.404 × 10–4*
 Male 130 (42.80) 244 (56.60)
 Female 174 (57.20) 187 (43.40)
Smoke, cigarettes/day, n (%) 1.227 × 10–17*
 No 253 (83.20) 248 (57.50)
 1–10 29 (9.50) 41 (9.50)
 > 11 22 (7.20) 142 (32.90)
Drink, n (%) 8.893 × 10–5*
 No 221 (72.70) 252 (58.50)
 Yes 83 (27.30) 179 (41.50)
TL, kb 6.74 (5.18, 8.43) 6.44 (4.88, 8.93) 0.144
Height, cm 165.0 (159.0, 172.0) 167.0 (160.0, 172.0) 0.324
Weight, kg 66.95 (57.10, 77.58) 70.00 (63.00, 77.80) 0.003*
BMI, kg/m2 24.31 (22.08, 27.16) 25.27 (23.07, 27.39) 0.003*
SBP, mmHg 124 (113, 136) 138 (125, 150) 1.087 × 10–16*
DBP, mmHg 79 (72, 88) 82 (76, 91) 9.324 × 10–7*
FPG, mmol/L 5.00 (4.70, 5.50) 5.17 (4.61, 6.00) 0.053
TG, mmol/L 1.26 (0.86, 1.80) 1.34 (1.00, 1.87) 0.017*
TC, mmol/L 4.50 (3.99, 5.05) 4.22 (3.47, 4.99) 2.451 × 10–4*
HDL‐C, mmol/L 1.19 (1.01, 1.38) 1.08 (0.91, 1.24) 5.497 × 10–9*
LDL‐C, mmol/L 2.53 (2.12, 2.92) 2.46 (1.92, 3.00) 0.232
ApoA1, g/L 1.26 (1.14, 1.36) 1.19 (1.07, 1.29) 1.727 × 10–9*
ApoB, g/L 0.98 (0.85, 1.19) 0.93 (0.73, 1.11) 1.845 × 10–4*
ApoB/ApoA1 ratio 0.79 (0.66, 1.01) 0.77 (0.61, 0.96) 0.198
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different between groups. There were no statistically 
significant differences in the genotype distribution of 
all SNP between the IS patients and the control group 
(Table  2). Four SNPs with MAF < 0.05 were excluded 
(MAF: 0.000 for rs6772228, 0.006 for rs9420907, 0.042 
for rs3027234, and 0.002 for rs6028466). SNPs that devi-
ated from Hardy–Weinberg equilibrium were excluded. 
Other eight SNPs, amongst the healthy controls, were all 
in accordance with the Hardy–Weinberg equilibrium.
Association estimates for individual SNPs
Association of each SNP with ln TL in all the assumed 
genetic models are shown in Additional file  1: Table  S1 
and Additional file 2: Table S2. To meet MR assumptions 
basically, two of the SNPs (rs11125529 and rs412658) 
were used as instrumental variables, and the unweighted 
GRS were constructed for non-linear MR analysis. By 
over-dominant model analysis, two SNPs in the control 
group were found to be associated with decreased TL, 
with risk genotype difference in ln TL of -0.108 (95% 
confidence interval (95% CI) − 0.204 to − 0.013) for 
rs11125529, − 0.089 (− 0.176 to − 0.001) for rs412658 
(Table 3). These two TL-related SNPs were not associated 
with the conventional risk factors or other biochemi-
cal indicators in the control group (Fig. 1). Furthermore, 
these two SNPs displayed no direct evidence for an 
Table 2 Genotype distributions of SNPs in IS patients and controls
IS ischemic stroke, SNP single nucleotide polymorphism, Chr chromosome
P < 0.05 is statistically significant
PHWE < 0.05 indicating that the SNP in control group was not satisfied Hardy–Weinberg equilibrium
SNP identifier Chr Gene Genotype Controls Cases P PHWE
rs11125529 2 ACYP2 0.433 1.000
C/C 202 (66.40%) 305 (70.80%)
C/A 92 (30.30%) 112 (26.00%)
A/A 10 (3.30%) 14 (3.20%)
rs10936599 3 MYNN 0.240 1.000
T/T 103 (33.90%) 121 (28.10%)
T/C 148 (48.70%) 225 (52.20%)
C/C 53 (17.40%) 85 (19.70%)
rs7726159 5 TERT 0.252 0.718
C/C 114 (37.50%) 155 (36.00%)
C/A 147 (48.40%) 195 (45.20%)
A/A 43 (14.10%) 81 (18.80%)
rs17653722 12 KRT80 0.800 0.654
G/G 220 (72.40%) 302 (70.10%)
G/T 76 (25.00%) 117 (27.10%)
T/T 8 (2.60%) 12 (2.80%)
rs8105767 19 LOC112268248 0.473 0.563
A/A 159 (52.30%) 215 (49.90%)
A/G 125 (41.10%) 177 (41.10%)
G/G 20 (6.60%) 39 (9.00%)
rs409627 19 ZNF676 0.639 0.304
G/G 129 (42.40%) 189 (43.90%)
G/C 145 (47.70%) 192 (44.50%)
C/C 30 (9.90%) 50 (11.60%)
rs412658 19 ZNF676 0.596 0.441
C/C 130 (42.80%) 188 (43.60%)
C/T 143 (47.00%) 190 (44.10%)
T/T 31 (10.20%) 53 (12.30%)
rs755017 20 ZBTB46 0.461 0.907
A/A 102 (33.60%) 163 (37.80%)
A/G 147 (48.40%) 199 (46.20%)
G/G 55 (18.10%) 69 (16.00%)
Page 6 of 10Cao et al. J Transl Med          (2020) 18:385 
individual association with IS risk (P > 0.05). The ORs for 
IS of risk genotype (“short TL”) were 0.810 (0.580, 1.120) 
for rs11125529, and 0.890 (0.660 to 1.190) for rs412658 
(Table 3). 
Association of TL with the IS risk
In this case–control study, the OR (95% CI) for IS was 
0.681 (0.469 to 0.982) adjusted for age and sex (Fig.  2). 
The association between TL and the IS risk was not sta-
tistically significant (OR (95% CI): 0.671 (0.437 to 1.031)) 
even after further adjusting for the smoking status, 
drinking status, and levels of BMI, SBP, DBP, FPG, TG, 
TC, HDL-C, LDL-C, ApoA1, ApoB.
Using rs11125529 and rs412658 as a proxy, the linear 
MR analysis provided no evidence of an overall associa-
tion between genetically predicted TL and IS risk (OR 
(95% CI): 1.312 (0.979 to 1.759) for the inverse-variance 
weighted method, 1.326 (0.932 to 1.888) for the maxi-
mum likelihood method, and 1.226 (0.844 to 1.781) 
for the mode-based estimation method), after adjust-
ing for the above-mentioned factors (Fig.  2). Using the 
unweighted GRS (rs11125529 and rs412658) as instru-
mental variables, three tests of nonlinearity MR analy-
sis failed to reject the null hypothesis (P = 0.069 for the 
quadratic test, P = 0.126 for the fractional polynomial 
test, and P = 0.260 for the Cochran’s Q test), indicating 
that the effect of telomere attrition on IS risk may not 
be non-linear. In Fig.  3, the box plot of TL between IS 
patients and controls across quintiles of the TL was also 
shown that there was no obvious non-linear TL-IS rela-
tionship. Two of five groups by the quintiles of TL, there 
were statistically significant differences in TL between 
the IS patients and the controls.
Discussion
Based on linear and non-linear MR analysis, we used TL-
related SNPs (or unweighted GRS) as proxies to clarify 
whether TL is causally relevant to IS or not. Our results 
showed no causal association between the genetically 
shortened TL and the increased IS risk.
Many epidemiologic studies have examined the rela-
tionship between TL and stroke risk, but results were 
Table 3 Candidate IVs and  their association with  TL 
and IS risk under over-dominant model
TL telomere length, IS ischemic stroke, MD mean difference, 95% CI 95% 
confidence interval, OR Odds ratio
* P < 0.05 is statistically significant
Association with ln TL 
in controls
Association with IS in all 
subjects
MD (95% CI) P OR (95% CI) P
rs11125529 0.026* 0.203
 C/C-A/A 0.000 (0.000, 0.000) 0.000 (0.000, 0.000)
 C/A − 0.108 (− 0.204, 
− 0.013)
0.810 (0.580, 1.120)
rs412658 0.049* 0.428
 C/C-T/T 0.000 (0.000, 0.000) 0.000 (0.000, 0.000)
 C/T − 0.089 (− 0.176, 
− 0.001)
0.890 (0.660, 1.190)
Variables
rs11125529 (No. of genotypes: CA/CC-AA, 92/212) rs412658 (No. of genotypes: CT/CC-TT, 143/161)
MD (95% CI) MD (95% CI) P MD (95% CI) MD (95% CI) P
Age, years -0.537 (-3.597, 2.524) 0.731 1.925 (-0.885, 4.734) 0.180
Height, cm -1.934 (-3.919, 0.052) 0.057 -0.273 (-2.111, 1.565) 0.771
Weight, kg -3.082 (-6.296, 0.133) 0.061 -1.559 (-4.530, 1.412) 0.305
BMI, kg/m2 -0.545 (-1.481, 0.390) 0.254 -0.494 (-1.355, 0.367) 0.262
SBP, mmHg 0.671 (-4.304, 5.646) 0.792 -0.985 (-5.563, 3.593) 0.674
DBP, mmHg -0.235 (-3.184, 2.713) 0.876 -1.661 (-4.369, 1.046) 0.230
FPG, mmol/L -0.067 (-0.313, 0.180) 0.595 -0.041 (-0.268, 0.186) 0.722
TG, mmol/L -0.129 (-0.359, 0.101) 0.273 -0.193 (-0.404, 0.019) 0.075
TC, mmol/L -0.110 (-0.328, 0.109) 0.325 -0.007 (-0.209, 0.194) 0.942
HDL-C, mmol/L 0.027 (-0.037, 0.092) 0.408 0.004 (-0.056, 0.063) 0.908
LDL-C, mmol/L -0.103 (-0.259, 0.054) 0.199 0.033 (-0.112, 0.177) 0.657
ApoA1, g/L 0.013 (-0.025, 0.051) 0.494 -0.013 (-0.048, 0.022) 0.459
ApoB, g/L -0.115 (-0.266, 0.036) 0.137 -0.006 (-0.146, 0.133) 0.932
ApoB/ApoA1 
ratio
-0.100 (-0.231, 0.031) 0.134 0.004 (-0.117, 0.125) 0.948
Fig. 1 Associations of two single nucleotide polymorphisms related to telomere length with various characteristics in individuals free from known 
ischemic stroke at time of measurement. MD mean difference, 95% CI 95% confidence interval, BMI body mass index, SBP systolic blood pressure, 
DBP diastolic blood pressure, FPG fasting plasma glucose, TG triglycerides, TC total cholesterol, HDL‐C high‐density lipoprotein cholesterol, LDL‐C 
low‐density lipoprotein cholesterol, ApoA1 apolipoprotein A1, ApoB apolipoprotein B.
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not consistent enough. Shorter TL were not signifi-
cantly associated with IS in the prospective and retro-
spective studies carried out in the Caucasian [15, 30, 
31]. A nested case–control study including 504 case–
control pairs of American female nurses showed a 
non-significant association between relative TL and IS 
(lowest vs. highest quartile: OR = 0.82, 95% CI 0.52–
1.32, P = 0.42) [15]. Consistent with findings from the 
retrospective study, a prospective study (1,136 Ameri-
can adults aged 65 years and older at baseline, average 
6.1  years of follow-up, 33 new cases of IS) reported 
that leukocyte TL change did not associate with IS 
(1st quartile vs. 4th quartile: relative risk (RR) = 1.61 
(95% CI 0.46–5.68; P = 0.46) [30]. Similarly, in a cohort 
study including 4,576 Danish at baseline (10  years of 
follow-up, 295 new case of IS), the adjusted RR of IS 
for TL (4th quartile vs. 1st quartile) were 0.95 (95% CI 
0.64–1.40; P = 0.60) [31]. In a case–control study car-
ried out in Wuhan (capital of Hubei Province, South 
China), including 1,309 stroke patients and 1,309 age- 
and sex-matched control subjects, OR (95% CI) for IS 
risk were 2.12 (1.62–2.77) compared the first quar-
tile (shortest) to the fourth (longest) quartile [14]. In 
another case–control study carried out in Shenzhen 
(Guangdong Province, South China) including 150 
cases of IS and 150 siblings of patients free of stroke, 
shortened TL was independently associated with IS 
(OR = 4.00, 95% CI 1.28–12.77) [32]. The present MR 
did not provide strong evidence of causal association 
between short TL and IS, consistent with findings from 
the prospective studies and the retrospective studies 
carried out in the Caucasian, while different to case–
control studies performed in the Chinese.
Despite previous retrospective observational studies 
reporting an TL-stroke association, such a relationship 
has not been firmly supported by evidence from prospec-
tive cohort studies. Subgroup analysis of four meta-anal-
ysis (stratified by study design) have shown consistent 
results that shorter TL were not significantly associated 
with stroke risk in prospective studies or in studies with 
a high quality score [18, 19, 33, 34]. In a recent meta-
analysis, shorter TL was associated with a significant 
11% higher risk for stroke (RR = 1.12, 95% CI 1.05–1.19), 
although with significant heterogeneity between stud-
ies (I2 = 81.1%, Phet < 0.001) [33]. After stratified by study 
design, the TL-IS relationship was not significance in 
those prospective studies (RR = 1.03, 95% CI 0.96–1.09) 
P OR (95% CI) 
ln TL (kb)
Adjusted for age, sex 0.041* 0.681 (0.469, 0.982)
Further adjusted† 0.069 0.671 (0.437, 1.031)
Linear MR analysis†
Inverse-variance weighted method 0.069 1.312 (0.979, 1.759)
Maximum likelihood method 0.117 1.326 (0.932, 1.888)
Mode-based estimation method 0.285 1.226 (0.844, 1.781)
Non-linear MR analysis†
The quadratic test 0.069
The fractional polynomial test 0.126
The Cochran’s Q test 0.260
Fig. 2 Estimates of association of telomere length (TL) and genetic prediction telomere with ischemic stroke risk. *P < 0.05 is statistically 
significant. † Corrected for regressions of TL and potential confounding factors, including age, sex, smoking status, drinking status, and levels of 
body mass index, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, triglycerides, total cholesterol, high‐density lipoprotein 
cholesterol, low‐density lipoprotein cholesterol, apolipoprotein A1, apolipoprotein B. OR odds ratio, 95% CI 95% confidence interval, ln TL Natural 
log-transformed telomere length, MR mendelian randomization.
Fig. 3 Box plot of telomere length across quintiles of the telomere 
length. P < 0.05 is statistically significant
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but remained significant in retrospective studies 
(RR = 1.81, 95% CI 1.54–2.13) [33]. MR analysis which 
simulates natural experiments based on genetic variants, 
is consider as an interface between cohort studies and the 
intervention trials at the evidence level [35]. The incon-
sistency might be explained by the confounding, reverse 
causation or recall bias, which might be avoided in MR 
analysis but not in observational studies.
Three linear MR studies based on two-sample MR 
design also presented inconsistent results in European 
ancestry. One MR analysis showed conflicting results 
which shorter TL was marginally statistically significantly 
associated with the decreased risk of stroke [21]. Another 
two linear MR analysis provided no evidence of the linear 
association between genetically predicted short TL and 
IS as well as its subtypes [22, 23]. Similarly, we also found 
null linear relationship between genetically predicted TL 
and IS risk in a Han Chinese population.
There are several possible explanations for the discrep-
ancy between retrospective and prospective cohort stud-
ies. One hypothesis is that TL had causal effect on IS risk 
under certain circumstances. Difference in factors, such 
as participant age range, TL measurement technique, and 
so on, might influence the TL-IS relationship. A previous 
study indicate that the positive association between short 
TL and the risk of stroke or post-stroke death might 
only exist in the seniors population (ranging from 65 to 
73  years old), therefore the effect of age might need to 
be taken into consideration in future studies [11]. How-
ever, people aged 65–73 years comprised a relatively low 
proportion of all participants (9.52%) in our research. 
Furthermore, although absolute TL measured by qPCR 
showed a strong correlation (r2 = 0.75, P < 0.0001) with 
the results obtained with terminal restriction fragment 
analysis (the gold standard for TL measurement). How-
ever, slightly difference in TL measurement could affect 
the TL-IS relationship [28].
Another hypothesis, based on epidemiological evi-
dence, explaining this contradiction is that shorter TL is 
inversely associated with the risk of IS, which means that 
TL may be a downstream biological consequence of the 
IS onset. Figure 3 illustrates that no clear linear or non-
linear relationship exists between TL and the risk of IS. 
However, not all of the differences between the TL and 
the IS risk were statistically significant within the differ-
ent TL groups, indicating that there may be a feedback 
mechanism within certain TL range. Additionally, age is 
one of the major risk factors of TL and IS, so the effect of 
age needs to be excluded to prove this hypothesis [7, 11]. 
Estimates from previous MR studies and our study have 
avoided the possibility of inverse association to some 
extent, but more work is still needed to be determined 
the possible role of TL. For example, bidirectional MR 
analysis may be further used to orient the causal direc-
tion of TL-IS relationship [36]. Otherwise, in terms of the 
conflicting results from different research designs, other 
possibility is that there is no association between TL and 
IS risk. At present, however, the mechanism research on 
the relationship of TL and IS is still lacking and lagging, 
and we cannot rule out the possibility that the existence 
of certain compensation mechanisms may have affected 
our results.
For the chief strengths of our study, we explored the 
possible shape of the potential causal relation between TL 
and IS risk in a one-sample MR framework using linear 
and non-linear MR methodology. As a result of the MR 
analysis, potential reverse causality was eliminated and 
confounding bias was reduced because genetic instru-
ments were not associated with individual risk factors 
that may affect results from conventional observational 
studies. Secondly, although the potential pleiotropic 
effects were unavoidable in this study, we searched com-
prehensively from genotype to phenotype to identify the 
potential pleiotropic effects and further provided possi-
ble evidence of the SNP instrument validity that the SNPs 
have no effect on available confounding factors, to reduce 
the likelihood of bias due to violation of the instrumental 
variable analysis. Furthermore, to our knowledge, this is 
the first linear and non-linear MR study assessing TL in 
relation to the IS risk in a Han Chinese population. Oth-
erwise, healthy controls were randomly recruited from 
the general population covering same geographical area, 
which could decrease the selection bias of the results.
This study also has some limitations. Firstly, MR analy-
sis has stringent assumptions [20]. Completely ruling out 
potentially pleiotropic effects or an additional biologi-
cal causal pathway is a challenge for all MR analyses. We 
are limited by current knowledge and other unavailable 
confounders, so we cannot exclude the possibility that 
our estimates are biased by currently unknown pleio-
tropic effects. Secondly, insufficient statistical power was 
a common limitation of one-sample MR analysis, and 
therefore we cannot exclude type II error as an explana-
tion for the null results [37]. Our study does not provide 
strong evidence for a positive linear or non-linear effect 
of TL on IS, but does not rule out that genetically pre-
dicted TL by unidentified genetic instruments might 
play a role. Finally, our study was conducted in middle 
to early late aged participants of Han Chinese descent 
based on Northern China. Further MR research needs to 
be explored in a larger and more representative samples, 
including those from a non-Asian ethnicity.
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Conclusion
In conclusion, although TL is associated with the risk of 
IS based on the conventional case–control analysis, this 
one-sample MR study suggests that negative association 
of TL with the IS risk is unlikely to be linear or non-linear 
causal. There is a need to identify the specific genetic, 
biochemical, and environmental biological mechanisms 
responsible for this association. Further research with 
larger sample sizes, which will be able to perform strati-
fied analysis by age or other strong risk factors, is nec-
essary to understand the causal pathways underpinning 
this association.
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